March 25, 2020 / 12:34 PM / in 16 days

BRIEF-Immunomedics Provides COVID-19 Business Continuity Update, Affirms 2020 Strategic Priorities, And Shares Research And Development And Regulatory Update

March 25 (Reuters) - Immunomedics Inc:

* IMMUNOMEDICS PROVIDES COVID-19 BUSINESS CONTINUITY UPDATE, AFFIRMS 2020 STRATEGIC PRIORITIES, AND SHARES RESEARCH AND DEVELOPMENT AND REGULATORY UPDATE

* IMMUNOMEDICS INC - REITERATES PLAN FOR TOPLINE UPDATE ON FULL 100-PATIENT COHORT OF TROPHY U-01 AT MEDICAL CONFERENCE IN H2 2020

* IMMUNOMEDICS INC - CONTINUES TO ACCRUE PROGRESSION-FREE SURVIVAL EVENTS FOR ASCENT, WITH A TOPLINE READOUT EXPECTED IN MID-2020 TIMEFRAME Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below